Concepedia

Efficacy and Toxicity of Moderately Hypofractionated Radiation Therapy with Helical TomoTherapy Versus Conventional Radiation Therapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer Receiving Concurrent Chemotherapy: A Multicenter, Randomized Phase 3 Trial

Qi Zhang, Shaonan Fan, Xiaohong Xu, Shisuo Du, Guangying Zhu, Chaoyang Jiang, Shi’an Xia, Qiwen Li, Qifeng Wang, Dong Qian,

International Journal of Radiation Oncology*Biology*Physics · 2024 · 15 citations · 27 references

DOIFull text

Open access

Concepts

References

27

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations

, , +14

The National Comprehensive Cancer Network

William T. McGivney · Cancer · 1998 · 16.9K citations

, , +15

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary

Claus Vogelmeier, Gerard J. Criner, Fernando J. Martínez et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 3.2K citations · Full text

, , +17

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

Jeffrey D. Bradley, Rebecca Paulus, Ritsuko Komaki et al. · The Lancet Oncology · 2015 · 2K citations · Full text

, , +17

Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Journal of Clinical Oncology · 2022 · 1.3K citations · Full text

, , +16